Literature DB >> 21685650

The development of the SWEAT questionnaire: a scale measuring costs and efforts inherent to conducting exposure sessions.

Geneviève Robillard1, Stéphane Bouchard, Stéphanie Dumoulin, Tanya Guitard.   

Abstract

For decades, empirical studies have shown the effectiveness of exposure techniques when used in cognitive-behavioral therapy (CBT) treatment for anxiety disorders. A few studies are now suggesting that using Virtual Reality (VR) may be an effective way to conduct exposure and overcome some of the limitations of in vivo exposure. The aim of this study is to validate the Specific Work for Exposure Applied in Therapy (SWEAT) questionnaire that measures costs and efforts required to conduct in vivo and in virtuo exposure. A total of 265 exposure sessions (in vivo = 140; in virtuo = 125) were rated by experienced psychologists. Reliability analysis revealed three main factors in the construct of the SWEAT questionnaire. Results also showed that conducting exposure in VR is less of a burden and more readily adapted to the patients' needs than in vivo.

Entities:  

Mesh:

Year:  2011        PMID: 21685650

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  2 in total

1.  STUDY PROTOCOL: EXPOSURE IN VIRTUAL REALITY FOR SOCIAL ANXIETY DISORDER - a randomized controlled superiority trial comparing cognitive behavioral therapy with virtual reality based exposure to cognitive behavioral therapy with in vivo exposure.

Authors:  Lars Clemmensen; Stéphane Bouchard; Johan Rasmussen; Trine Theresa Holmberg; Jakob Hyldig Nielsen; Jens Richardt Møllegaard Jepsen; Mia Beck Lichtenstein
Journal:  BMC Psychiatry       Date:  2020-01-30       Impact factor: 3.630

Review 2.  The Simulation Game-Virtual Reality Therapy for the Treatment of Social Anxiety Disorder: A Systematic Review.

Authors:  Pasquale Caponnetto; Sergio Triscari; Marilena Maglia; Maria C Quattropani
Journal:  Int J Environ Res Public Health       Date:  2021-12-15       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.